Several explanations have been proposed, either that adrenal cancer cells develop a tolerance to this inhibitor of cell cycle progression, suggesting that p27 could be present but inactive to arrest the cell cycle, or that p27 gene is mutated resulting in a modified p27 protein [47,54]. This evidence concerns the gene CDKN1B and adrenal gland cancer.